Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AmerisourceBergen

Chart of the Day: AmerisourceBergen - Healthcare Giant

The Chart of the Day belongs to the healthcare company AmerisourceBergen (ABC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

Barchart

‘Too many are dying’; drug companies’ opioid settlement to help Chicago aid drug users

Heather O’Donnell of the Chicago social services agency Thresholds says the money is “an opportunity to really build up substance use care.”

Chicago Sun-Times

Feds sue drug wholesaler AmerisourceBergen over opioid sales

The U.S. Justice Department is alleging that a major drug wholesaler contributed to the deadly toll from opioids by turning a blind eye to warning signs about suspicious sales to its pharmacy customers

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Feds sue AmerisourceBergen over 'hundreds of thousands' of alleged opioid violations

DOJ officials say the drug wholesaler could face "billions of dollars" in penalties for failing to report diversion of prescription opioid pain medications shipped to pharmacies across the U.S.

WEKU

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022

Upgrades

Benzinga

WVa cities, counties reach $400M settlement with drug firms

West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors

The Independent UK

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years by 2.86% on an annualized basis producing an average annual return of 14.13%. Currently, AmerisourceBergen has a market capitalization of $30.43 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Where AmerisourceBergen Stands With Analysts

Analysts have provided the following ratings for AmerisourceBergen (NYSE:ABC) within the last quarter:

Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 20 years by 3.28% on an annualized basis producing an average annual return of 10.4%. Currently, AmerisourceBergen has a market capitalization of $30.65 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

Upgrades

Benzinga

Here's How Much You Would Have Made Owning AmerisourceBergen Stock In The Last 20 Years

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 20 years by 3.71% on an annualized basis producing an average annual return of 10.86%. Currently, AmerisourceBergen has a market capitalization of $32.37 billion.

Benzinga

Analyst Ratings for AmerisourceBergen

Within the last quarter, AmerisourceBergen (NYSE:ABC) has observed the following analyst ratings:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

AmerisourceBergen Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q2, AmerisourceBergen (NYSE:ABC) earned $555.25 million, a 23.55% increase from the preceding quarter. AmerisourceBergen's sales decreased to $57.72 billion, a 3.2% change since Q1.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Moderna And 3 Other Stocks Insiders Are Selling

US crude oil futures traded lower, dropping around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades.

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

The Independent UK

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

Benzinga

What's Going On With AmerisourceBergen Shares Today

Walgreens Boots Alliance Inc (NASDAQ:WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE:ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%. Chief Operating Officer, International of Walgreens Boots Alliance, Ornella Barra, will continue to serve on AmerisourceBergen's Board of Directors. WBA…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

AmerisourceBergen Lifts FY22 Guidance As Q2 Earnings Beats Estimates

AmerisourceBergen Corp's (NYSE:ABC) Q2 FY22 adjusted EPS reached $3.22, up 27.3% Y/Y, beating the consensus of $2.93. Revenue of $57.7 billion increased by 17.4% Y/Y, beating the analyst consensus of $57.27 billion, reflecting a 585.3% increase in revenue within International Healthcare Solutions, primarily driven by the June 2021 acquisition of Alliance Healthcare…

Benzinga

Recap: AmerisourceBergen Q2 Earnings

AmerisourceBergen (NYSE:ABC) reported its Q2 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

The Independent UK

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

The Independent UK

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers

The Independent UK

US drug czar testifies in WVa lawsuit against opioid makers

The new White House drug czar has testified that the opioid epidemic got so bad in drug-ravaged West Virginia that the state was having trouble finding foster parents to care for children

The Independent UK

Trial begins in West Virginia lawsuit against opioid makers

Opening arguments have taken place in a West Virginia lawsuit accusing several drugmakers of misrepresenting the risks and benefits of opioids

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.